About Sanyou Biopharmaceuticals
Sanyou Biopharmaceuticals is a biotechnology company founded in 2015 and headquartered in Shanghai, China, specializing in research, development and services for innovative antibody-based biologics. Its flagship platform is a super-trillion-scale antibody library combined with phage display and mammalian cell expression technologies and artificial-intelligence tools for candidate discovery.
The company provides integrated CRO, development (CDO), innovative product (CPO) and characteristic reagent (CRS) services: antibody discovery and optimization, humanization, affinity maturation, antigen production, cell line construction, fermentation and purification process development, in vitro and in vivo efficacy evaluation, and development of antibody-drug conjugates (ADC), bispecific antibodies and nanobodies. Its integrated R&D laboratory brings together ten functional modules and more than 40 core technology platforms.
Sanyou reports collaborations with more than 2,000 pharmaceutical and biotechnology companies and over 1,200 new drug discovery and development projects powered by its platform. With business centres across Asia, North America and Europe, it serves biopharmaceutical and diagnostics clients looking to shorten the path from target identification to preclinical development.
The company provides integrated CRO, development (CDO), innovative product (CPO) and characteristic reagent (CRS) services: antibody discovery and optimization, humanization, affinity maturation, antigen production, cell line construction, fermentation and purification process development, in vitro and in vivo efficacy evaluation, and development of antibody-drug conjugates (ADC), bispecific antibodies and nanobodies. Its integrated R&D laboratory brings together ten functional modules and more than 40 core technology platforms.
Sanyou reports collaborations with more than 2,000 pharmaceutical and biotechnology companies and over 1,200 new drug discovery and development projects powered by its platform. With business centres across Asia, North America and Europe, it serves biopharmaceutical and diagnostics clients looking to shorten the path from target identification to preclinical development.